搜尋結果
US Agency to Reclassify Marijuana as a Less Dangerous Drug
Bloomberg· 5 日前Have a confidential tip for our reporters? WASHINGTON (AP) — The U.S. Drug Enforcement Administ ...
Amgen scraps experimental weight loss pill, moves forward with injection
CNBC· 3 日前Amgen on Thursday said it will stop developing its experimental weight loss pill and instead ...
California Cuts Cost of Overdose-Reversal Drug by 40% in Generic Deal
Bloomberg· 6 日前California is stepping up efforts to combat surging opioid-related deaths by teaming with a ...
Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply
Bloomberg· 3 日前Have a confidential tip for our reporters? Shortages have left patients already on the ...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters· 3 日前, opens new tab missed Wall Street estimates for quarterly profit on Thursday, hurt by softer ...
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
CNBC· 6 日前A federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers ...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 4 日前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ...
Zoetis Stock Jumps After Sales Beat, Leaders Emphasize Safety of Key Arthritis Drugs
The Wall Street Journal· 3 日前Zoetis jumped more than 6% in Thursday morning trading as leaders of the animal-health company ...
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg· 3 日前Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by ...
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 3 日前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), ...